4
Changes in Ownership
INSMED Inc Filed Acc 0001628280-25-016508
Chair and CEO sold 6,830 shares at an average $73.58 ($502,577)
- Chair and CEO acquired 6,830 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lewis William · Chair and CEO
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-04-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +6,830 | $10.85 | $74,106 | 240,754 | I |
| 2025-04-01 | Sale : show line 2 in the form 10b5-1 | −3,021 | $72.29 | $218,388 | 237,733 | I |
| 2025-04-01 | Sale : show line 3 in the form 10b5-1 | −772 | $73.44 | $56,696 | 236,961 | I |
| 2025-04-01 | Sale : show line 4 in the form 10b5-1 | −2,232 | $74.78 | $166,909 | 234,729 | I |
| 2025-04-01 | Sale : show line 5 in the form 10b5-1 | −805 | $75.26 | $60,584 | 233,924 | I |
| Open-market sales · 6,830 sh · avg $73.58 · $502,577 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-04-01 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (right to buy) | −6,830 | 184,480 | I |
Loading xslF345X05/wk-form4_1743711913.xml…